Braizon Therapeutics, Inc.

BRAIN ACCESS

Custom manufacture of pharmaceuticals; processing of medicinal materials; Custom manufacture of chemicals, except for chemicals for in vitro diagnostic use;Pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for the treatment of central nervous system disorders; pharmaceutical preparations for the prevention of central nervous system diseases; pharmaceutical preparations for the prevention of central nervous system disorders; pharmaceutical preparations for the treatment of dementia, Alzheimer's disease, schizophrenia, depressive disorder, depression, and autism spectrum disorder; pharmaceutical preparations for the prevention of dementia, Alzheimer's disease, schizophrenia, depressive disorder, depression, and autism spectrum disorder; pharmaceutical preparations for the brain for the treatment of central nervous system diseases; pharmaceutical preparations for the brain for the treatment of central nervous system disorders; pharmaceutical preparations for the brain for the prevention of central nervous system diseases; pharmaceutical preparations for the brain for the prevention of central nervous system disorders; pharmaceutical preparations for the brain for treatment of dementia, Alzheimer's disease, schizophrenia, depressive disorder, depression, and autism spectrum disorder; pharmaceutical preparations for the brain for the prevention of dementia, Alzheimer's disease, schizophrenia, depressive disorder, depression, and autism spectrum disorder; pharmaceutical preparations for drug delivery systems which deliver medicament for the brain into the brain for the treatment of central nervous system diseases; pharmaceutical preparations for drug delivery systems which deliver medicament for the brain into the brain for the treatment of central nervous system disorders; pharmaceutical preparations for drug delivery systems which deliver medicament for the brain into the brain for the prevention of central nervous system diseases; pharmaceutical preparations for drug delivery systems which deliver medicament for the brain into the brain for the prevention of central nervous system disorders; pharmaceutical preparations for drug delivery systems which deliver medicament for the brain into the brain for the treatment of dementia, Alzheimer's disease, schizophrenia, depressive disorder, depression, and autism spectrum disorder; pharmaceutical preparations for drug delivery systems which deliver medicament for the brain into the brain for the prevention of dementia, Alzheimer's disease, schizophrenia, depressive disorder, depression, and autism spectrum disorder; dietary supplements for humans; dietary supplements for animals; in vivo diagnostic agents for medical purposes specifically for analyzing the central nervous system; radio-isotope markers for therapeutic or in vivo diagnostic use;Chemicals, namely, chemicals for in vivo industrial use for analyzing the central nervous system; chemicals used in industry for in vivo analysis of the central nervous system;BRAIN;Testing, inspection or research of pharmaceuticals, chemicals or cosmetics, except for chemicals for in vitro diagnostic use; testing the functionality of machines, except for machines for in vitro diagnostic use; research on machines, except for machines for in vitro diagnostic use;

BRAIZON THERAPEUTICS

THERAPEUTICS;Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff;

BRAIZON THERAPEUTICS

The mark consists of the term BRAIZON in the color blue over the term THERAPEUTICS in the color gray, with a green arced line traversing the letters of the term BRAIZON.;The color(s) blue, green, and gray is/are claimed as a feature of the mark.;THERAPEUTICS;Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff;